nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A dynamic opportunity for drug discovery
|
Ewan, Scott G |
|
2004 |
9 |
13 |
p. 546- 1 p. |
artikel |
2 |
Automated high-throughput patch-clamp techniques
|
Shieh, Char-Chang |
|
2004 |
9 |
13 |
p. 551-552 2 p. |
artikel |
3 |
Catalytic antioxidants: a radical approach to new therapeutics
|
Day, Brian J |
|
2004 |
9 |
13 |
p. 557-566 10 p. |
artikel |
4 |
Janet Woodcock discusses the FDA and the drug development process
|
Watson, Christopher |
|
2004 |
9 |
13 |
p. 548-550 3 p. |
artikel |
5 |
Monitor - biology
|
Williams, Ruth R.E |
|
2004 |
9 |
13 |
p. 583-585 3 p. |
artikel |
6 |
Monitor - business
|
Clough, Joanne |
|
2004 |
9 |
13 |
p. 585- 1 p. |
artikel |
7 |
Monitor - chemistry
|
Mustata, Gabriela |
|
2004 |
9 |
13 |
p. 582-583 2 p. |
artikel |
8 |
Monitor - people
|
Clough, Joanne |
|
2004 |
9 |
13 |
p. 586- 1 p. |
artikel |
9 |
Neurodegenerative disease research in the 21st century
|
Bales, Kelly R |
|
2004 |
9 |
13 |
p. 553-556 4 p. |
artikel |
10 |
NIH pumps money into biodefence
|
Li, Anthony |
|
2004 |
9 |
13 |
p. 547- 1 p. |
artikel |
11 |
Real options are neither complicated nor unrealistic
|
Villiger, Ralph |
|
2004 |
9 |
13 |
p. 552-553 2 p. |
artikel |
12 |
The implications of polymorphisms in mammalian flavin-containing monooxygenases in drug discovery and development
|
Cashman, John R |
|
2004 |
9 |
13 |
p. 574-581 8 p. |
artikel |
13 |
The pharmaceutical industry in the Arab world: challenges, controversies, and future outlook
|
Kandil, Osama |
|
2004 |
9 |
13 |
p. 543-545 3 p. |
artikel |
14 |
Translating pharmacogenetics and pharmacogenomics into drug development for clinical pediatrics and beyond
|
Leeder, J.Steven |
|
2004 |
9 |
13 |
p. 567-573 7 p. |
artikel |